Global Stable Isotope Labeled Biomolecules Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
This report studies the Stable Isotope Labeled Biomolecules market, Stable Isotope Labeled Biomolecules refer to the biomolecule which is labeled by replacing specific atoms by their isotope, and then the reactant is then allowed to undergo the reaction.
BR>An important tool for high-resolution structure determination for NMR spectroscopy is the use of stable isotopically labeled biomolecules. By either selectively or uniformly incorporating stable isotopes into proteins, the user is able to significantly reduce the complexity of their spectra. D Labeled Biomolecules, 15N, and deuterium are the most common isotopes incorporated into proteins. Microbial expression systems, cell-free extracts, peptide synthesis and custom synthesis provide a variety of options for accomplishing the incorporation of the labels. Microbial expression systems are cell-based protein expression systems in which the microbes are grown in either a defined or complex media with D Labeled Biomolecules labeled glucoses and 15N Labeled Biomoleculeslabeled ammonium salts as the sole sources of carbon and nitrogen respectively. Ease of use, adaptability and high protein yields have made these expression systems the most popular technique for stable isotope incorporation. Cell-free extracts and custom synthesis also present their own individual advantages with the use of uniformly or selectively labeled amino acids. Cell-free extracts allow the user to more readily implement high-throughput in vitro protein expression as many proteins are difficult to express in vivo due to complications such as toxicity. Custom synthesis allows for unique, site-specific incorporation of isotopes into peptides allowing the user to study distinct structural regions.
According to APO Research, The global Stable Isotope Labeled Biomolecules market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Stable Isotope Labeled Biomolecules include Cambridge Isotope Laboratories, Sigma-Aldrich, Thermo Fisher Scientific, LGC Standards, Toronto Research Chemicals, IsoLife, WITEGA Laboratorien, Omicron Biochemicals and Icon Isotopes, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Stable Isotope Labeled Biomolecules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Stable Isotope Labeled Biomolecules, also provides the sales of main regions and countries. Of the upcoming market potential for Stable Isotope Labeled Biomolecules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Stable Isotope Labeled Biomolecules sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Stable Isotope Labeled Biomolecules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Stable Isotope Labeled Biomolecules sales, projected growth trends, production technology, application and end-user industry.
Stable Isotope Labeled Biomolecules segment by Company
Cambridge Isotope Laboratories
Sigma-Aldrich
Thermo Fisher Scientific
LGC Standards
Toronto Research Chemicals
IsoLife
WITEGA Laboratorien
Omicron Biochemicals
Icon Isotopes
Medical Isotopes
Stable Isotope Labeled Biomolecules segment by Type
D Labeled Biomolecules
15N Labeled Biomolecules
13C Labeled Biomolecules
Others
Stable Isotope Labeled Biomolecules segment by Application
Scientific Research
Medical
Industrial
Others
Stable Isotope Labeled Biomolecules segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives1. To analyze and research the global Stable Isotope Labeled Biomolecules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Stable Isotope Labeled Biomolecules market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Stable Isotope Labeled Biomolecules significant trends, drivers, influence factors in global and regions.
6. To analyze Stable Isotope Labeled Biomolecules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stable Isotope Labeled Biomolecules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stable Isotope Labeled Biomolecules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stable Isotope Labeled Biomolecules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter OutlineChapter 1: Provides an overview of the Stable Isotope Labeled Biomolecules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Stable Isotope Labeled Biomolecules industry.
Chapter 3: Detailed analysis of Stable Isotope Labeled Biomolecules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Stable Isotope Labeled Biomolecules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Stable Isotope Labeled Biomolecules in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.